These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34454297)

  • 21. Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI.
    Park SH; Kim H; Kim EK; Kim H; Choi DK; Chung YE; Kim MJ; Choi JY
    Oncotarget; 2017 Sep; 8(41):71012-71023. PubMed ID: 29050339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 10- and 20-min hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping for liver function assessment in clinic.
    Zhou ZP; Long LL; Qiu WJ; Cheng G; Huang LJ; Yang TF; Huang ZK
    Abdom Radiol (NY); 2017 Sep; 42(9):2272-2278. PubMed ID: 28396918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging features of hepatic inflammatory pseudotumor: distinction from colorectal liver metastasis using gadoxetate disodium-enhanced magnetic resonance imaging.
    Ichikawa S; Motosugi U; Suzuki T; Shimizu T; Onishi H
    Abdom Radiol (NY); 2020 Aug; 45(8):2400-2408. PubMed ID: 32468212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?
    Sofue K; Tsurusaki M; Murakami T; Onoe S; Tokue H; Shibamoto K; Arai Y; Sugimura K
    Eur Radiol; 2014 Oct; 24(10):2532-9. PubMed ID: 24865698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases.
    Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T
    Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.
    Shin NY; Kim MJ; Lim JS; Park MS; Chung YE; Choi JY; Kim KW; Park YN
    Eur Radiol; 2012 Apr; 22(4):864-71. PubMed ID: 22108766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
    Ding Y; Rao SX; Chen C; Li R; Zeng MS
    Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
    Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
    World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma.
    Chen Y; Qin X; Long L; Zhang L; Huang Z; Jiang Z; Li C
    J Magn Reson Imaging; 2020 Jun; 51(6):1755-1763. PubMed ID: 31675163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
    Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C
    Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
    AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
    [No Abstract]   [Full Text] [Related]  

  • 32. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
    Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases.
    Koh DM; Collins DJ; Wallace T; Chau I; Riddell AM
    Br J Radiol; 2012 Jul; 85(1015):980-9. PubMed ID: 22167501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases.
    Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K
    Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?
    Tajima T; Akahane M; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Kokudo N; Ohtomo K
    Jpn J Radiol; 2012 Oct; 30(8):648-58. PubMed ID: 22836904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
    Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
    Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.